Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Anika Therapeutics (ANIK) Other Working Capital Changes (2016 - 2025)

Historic Other Working Capital Changes for Anika Therapeutics (ANIK) over the last 16 years, with Q3 2025 value amounting to -$219000.0.

  • Anika Therapeutics' Other Working Capital Changes fell 19864.86% to -$219000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$2.6 million, marking a year-over-year decrease of 4136.24%. This contributed to the annual value of -$2.1 million for FY2024, which is 311.77% up from last year.
  • Latest data reveals that Anika Therapeutics reported Other Working Capital Changes of -$219000.0 as of Q3 2025, which was down 19864.86% from -$1.0 million recorded in Q2 2025.
  • In the past 5 years, Anika Therapeutics' Other Working Capital Changes registered a high of $1.2 million during Q1 2022, and its lowest value of -$2.0 million during Q3 2022.
  • For the 5-year period, Anika Therapeutics' Other Working Capital Changes averaged around -$439894.7, with its median value being -$241000.0 (2022).
  • Per our database at Business Quant, Anika Therapeutics' Other Working Capital Changes tumbled by 201250.0% in 2021 and then surged by 146666.67% in 2022.
  • Anika Therapeutics' Other Working Capital Changes (Quarter) stood at $238000.0 in 2021, then tumbled by 281.09% to -$431000.0 in 2022, then crashed by 208.82% to -$1.3 million in 2023, then decreased by 18.56% to -$1.6 million in 2024, then soared by 86.12% to -$219000.0 in 2025.
  • Its last three reported values are -$219000.0 in Q3 2025, -$1.0 million for Q2 2025, and $203000.0 during Q1 2025.